Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer
- PMID: 10637069
- DOI: 10.1006/gyno.1999.5659
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer
Abstract
Objective: PTEN/MMAC1, a candidate tumor suppressor gene located at chromosome 10q23.3, was recently identified and found to be homozygously deleted or mutated in several different types of human tumors. The aim of this study is to determine whether PTEN/MMAC1 is a target for 10q loss of heterozygosity in cervical cancer.
Method: We examined 50 primary cervical carcinoma specimens using a PCR-based assay followed by SSCP and direct sequencing. The genomic DNA was also confirmed by Southern blot analysis.
Results: All specimens except one, which has a 7-base deletion, showed a negative result. Among them, 30 randomly selected cases and their paired noncancerous tissue were further screened using nested RT-PCR. Six of 30 cervical cancerous tissues had aberrant transcripts. However, 4 of the matched noncancerous tissues also had aberrant transcripts. Southern blot analysis of the entire genomic DNA did not reveal any evidence of gene alteration.
Conclusions: Sequence abnormalities in the PTEN/MMAC1 gene were only detected in 1 of 50 cervical cancers analyzed indicating that aberrant PTEN/MMAC1 function is an uncommon event in the development of cervix cancers. However, similar to studies with the TSG101 gene, screening for aberrant transcripts of PTEN/MMAC1 with nested RT-PCR may detect transcripts, which, although they vary from the normal size, may not be related to oncogenesis as they are also frequently found in normal tissues of the same patient.
Copyright 2000 Academic Press.
Similar articles
-
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma.Cancer Invest. 2000;18(2):123-9. doi: 10.3109/07357900009038243. Cancer Invest. 2000. PMID: 10705874
-
Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.Anticancer Res. 1999 Sep-Oct;19(5B):3841-6. Anticancer Res. 1999. PMID: 10628321
-
Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.Cancer Res. 1998 Jan 15;58(2):204-9. Cancer Res. 1998. PMID: 9443392
-
Are aberrant transcripts of FHIT, TSG101, and PTEN/MMAC1 oncogenesis related?Int J Mol Med. 1999 May;3(5):491-5. doi: 10.3892/ijmm.3.5.491. Int J Mol Med. 1999. PMID: 10202180 Review.
-
Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.J Natl Cancer Inst. 1999 Nov 17;91(22):1922-32. doi: 10.1093/jnci/91.22.1922. J Natl Cancer Inst. 1999. PMID: 10564676 Review.
Cited by
-
PTEN downregulation induces apoptosis and cell cycle arrest in uterine cervical cancer cells.Exp Ther Med. 2021 Oct;22(4):1100. doi: 10.3892/etm.2021.10534. Epub 2021 Aug 2. Exp Ther Med. 2021. PMID: 34504554 Free PMC article.
-
Indole-3-carbinol prevents PTEN loss in cervical cancer in vivo.Mol Med. 2005 Jan-Dec;11(1-12):59-63. doi: 10.2119/2006-00007.Auborn. Mol Med. 2005. PMID: 16557333 Free PMC article.
-
Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.J Clin Invest. 2010 Jun;120(6):2094-108. doi: 10.1172/JCI40778. Epub 2010 May 10. J Clin Invest. 2010. PMID: 20458142 Free PMC article.
-
Downregulation of CCR5 inhibits the proliferation and invasion of cervical cancer cells and is regulated by microRNA-107.Exp Ther Med. 2016 Feb;11(2):503-509. doi: 10.3892/etm.2015.2911. Epub 2015 Dec 4. Exp Ther Med. 2016. PMID: 26893637 Free PMC article.
-
New novel non-MHC genes were identified for cervical cancer with an integrative analysis approach of transcriptome-wide association study.J Cancer. 2021 Jan 1;12(3):840-848. doi: 10.7150/jca.47918. eCollection 2021. J Cancer. 2021. PMID: 33403041 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials